随着新冠病毒感染病例激增，以下是关于最新的严重急性呼吸综合征冠状病毒2（SARS-CoV-2）“关注变体”JN.1的相关信息。 - Suppr

Suppr

超能文献

As COVID-19 Cases Surge, Here's What to Know About JN.1, the Latest SARS-CoV-2 "Variant of Interest".

作者信息

Rubin Rita

出版信息

JAMA. 2024 Feb 6;331(5):382-383. doi: 10.1001/jama.2023.27841.

DOI:10.1001/jama.2023.27841

PMID:38214935

Abstract

摘要

相似文献

As COVID-19 Cases Surge, Here's What to Know About JN.1, the Latest SARS-CoV-2 "Variant of Interest".随着新冠病毒感染病例激增，以下是关于最新的严重急性呼吸综合征冠状病毒2（SARS-CoV-2）“关注变体”JN.1的相关信息。

JAMA. 2024 Feb 6;331(5):382-383. doi: 10.1001/jama.2023.27841.

Will Omicron end the pandemic? Here's what experts say.奥密克戎会终结这场大流行吗？以下是专家们的看法。

Nature. 2022 Feb;602(7895):20-21. doi: 10.1038/d41586-022-00210-7.

Omicron Has Reached the US-Here's What Infectious Disease Experts Know About the Variant.奥密克戎毒株已抵达美国——以下是传染病专家对该变种毒株的了解。

JAMA. 2021 Dec 28;326(24):2460-2462. doi: 10.1001/jama.2021.22619.

What to Know About EG.5, the Latest SARS-CoV-2 "Variant of Interest".关于新型严重急性呼吸综合征冠状病毒2（SARS-CoV-2）“关注变异株”EG.5，你需要了解的信息。

JAMA. 2023 Sep 12;330(10):900-901. doi: 10.1001/jama.2023.16498.

Are new Omicron subvariants a threat? Here's how scientists are keeping watch.新型奥密克戎亚变体构成威胁吗？以下是科学家的监测方式。

Nature. 2022 Apr;604(7907):605-606. doi: 10.1038/d41586-022-01069-4.

The Emergence of SARS-CoV-2 Variant(s) and Its Impact on the Prevalence of COVID-19 Cases in the Nabatieh Region, Lebanon.SARS-CoV-2 变异株的出现及其对黎巴嫩纳巴提耶地区 COVID-19 病例流行的影响。

Med Sci (Basel). 2021 Jun 2;9(2):40. doi: 10.3390/medsci9020040.

Fast-Spreading JN.1: What You Need to Know About the Latest COVID-19 Subvariant.快速传播的JN.1：关于最新新冠病毒变异株你需要了解的信息

J Infect Public Health. 2024 Jul;17(7):102451. doi: 10.1016/j.jiph.2024.05.039. Epub 2024 May 14.

COVID derailed learning for 1.6 billion students. Here's how schools can help them catch up.新冠疫情使16亿学生的学习受到影响。以下是学校可以帮助他们追赶进度的方法。

Nature. 2022 May;605(7911):608-611. doi: 10.1038/d41586-022-01387-7.

JN.1: ongoing considerations of the shifting landscape of SARS-CoV-2 variants.JN.1：对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）变体不断变化格局的持续思考。

Future Microbiol. 2024;19(7):559-562. doi: 10.2217/fmb-2024-0010. Epub 2024 Apr 17.

Anticipating the future of the COVID-19 pandemic: insights into the emergence of SARS-CoV-2 variant JN.1 and its projected impact on older adults.展望新冠疫情的未来：深入了解新冠病毒变异株JN.1的出现及其对老年人的预计影响。

Geroscience. 2024 Jun;46(3):2879-2883. doi: 10.1007/s11357-024-01066-7. Epub 2024 Jan 10.

引用本文的文献

The Challenge of Long COVID: Is the Pandemic Really Over?长新冠的挑战：疫情真的结束了吗？

Public Health Rep. 2025 Aug 17:333549251358665. doi: 10.1177/00333549251358665.

Pregnancy reduces COVID-19 vaccine immunity against novel variants.怀孕会降低新冠疫苗对新型变体的免疫力。

NPJ Vaccines. 2025 Aug 13;10(1):191. doi: 10.1038/s41541-025-01236-4.

Clinical effectiveness of oral antiviral treatment for non-hospitalized high-risk patients with COVID-19 during Omicron JN.1 subvariant wave: a US-based propensity-matched cohort study.奥密克戎 JN.1 亚变体流行期间口服抗病毒治疗对非住院 COVID-19 高危患者的临床疗效：一项基于美国的倾向匹配队列研究。

Pneumonia (Nathan). 2025 May 25;17(1):12. doi: 10.1186/s41479-025-00168-w.

Composite outcome of oral azvudine vs. nirmatrelvir-ritonavir in COVID-19 patients: a retrospective cohort study.新冠病毒感染患者中口服阿兹夫定与奈玛特韦-利托那韦的复合结局：一项回顾性队列研究

Front Pharmacol. 2025 Apr 4;16:1546787. doi: 10.3389/fphar.2025.1546787. eCollection 2025.

Distal protein-protein interactions contribute to nirmatrelvir resistance.远端蛋白质-蛋白质相互作用导致对奈玛特韦耐药。

Nat Commun. 2025 Feb 1;16(1):1266. doi: 10.1038/s41467-025-56651-x.

A prediction approach to COVID-19 time series with LSTM integrated attention mechanism and transfer learning.一种结合长短期记忆网络（LSTM）集成注意力机制和迁移学习的新冠疫情时间序列预测方法。

BMC Med Res Methodol. 2024 Dec 31;24(1):323. doi: 10.1186/s12874-024-02433-w.

Daphnetin may protect from SARS-CoV-2 infection by reducing ACE2.瑞香素可能通过降低血管紧张素转换酶2（ACE2）来预防新型冠状病毒（SARS-CoV-2）感染。

Sci Rep. 2024 Dec 28;14(1):30682. doi: 10.1038/s41598-024-79734-z.

Development of a diagnostic multivariable prediction model of a positive SARS-CoV-2 RT-PCR result in healthcare workers with suspected SARS-CoV-2 infection in hospital settings.针对医院环境中疑似感染SARS-CoV-2的医护人员，开发一种用于预测SARS-CoV-2逆转录聚合酶链反应（RT-PCR）结果呈阳性的诊断多变量预测模型。

PLoS One. 2024 Dec 26;19(12):e0316207. doi: 10.1371/journal.pone.0316207. eCollection 2024.

Jun12682, a potent SARS-CoV-2 papain-like protease inhibitor with exceptional antiviral efficacy in mice.Jun12682，一种强效的严重急性呼吸综合征冠状病毒2（SARS-CoV-2）木瓜样蛋白酶抑制剂，在小鼠中具有卓越的抗病毒功效。

Acta Pharm Sin B. 2024 Sep;14(9):4189-4192. doi: 10.1016/j.apsb.2024.07.001. Epub 2024 Jul 6.

Antigenic sin and multiple breakthrough infections drive converging evolution of COVID-19 neutralizing responses.抗原性失误和多次突破性感染推动 COVID-19 中和反应趋同进化。

Cell Rep. 2024 Sep 24;43(9):114645. doi: 10.1016/j.celrep.2024.114645. Epub 2024 Aug 27.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验